Douglas A. Rich
Nessuna posizione attualmente
Patrimonio netto: 9 617 $ in data 30/11/2023
Storia della carriera di Douglas A. Rich
Precedenti posizioni note di Douglas A. Rich
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| APPLIED MOLECULAR TRANSPORT INC. | Direttore Tecnico/Scientifico/R&S | 19/01/2021 | 27/12/2023 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | 01/01/2011 | 01/01/2014 |
| UNITY BIOTECHNOLOGY, INC. | Direttore operativo | 01/04/2017 | - |
| KYTHERA BIOPHARMACEUTICALS INC | Direttore operativo | 01/05/2014 | - |
Formazione di Douglas A. Rich
| University of Southern California | Undergraduate Degree |
| Pepperdine University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Borsa valori
- Insiders
- Douglas A. Rich
- Esperienza
